Zomedica Announces Name Change

Rhea-AI Summary

Zomedica Corp. (NYSE American: ZOM), a veterinary health company, has officially changed its legal name from Zomedica Pharmaceuticals Corp., effective October 5, 2020. This decision, approved by shareholders on September 25, 2020, aims to reflect the company's focus on point-of-care diagnostic products for companion animals. Existing shareholders will not need to take any action regarding this change, although the CUSIP and ISIN numbers for shares have been updated. Interim CEO Robert Cohen expressed optimism about the company's strategic initiatives and future commercialization plans.

Positive

• Name change aligns with the company's focus on diagnostic products.
• Shareholder approval reflects confidence in the company's direction.
• Ongoing progress in strategic initiatives and commercialization plans.

Negative

• None.

ANN ARBOR, Mich., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic products for companion animals, announced that it has changed its legal name to Zomedica Corp. The Company’s stock trading symbol will remain as ZOM on the NYSE American and the shares will begin trading under the new name effective on October 5, 2020.

The Company’s board of directors approved the implementation of the name change following approval from the shareholders at the Annual General and Special Virtual-Only Meeting of shareholders held on September 25, 2020.

No action will be required by existing shareholders with respect to the name change. As a result of the name change, the Company’s common share CUSIP number is changed to 98980M109 and the ISIN is changed to CA98980M1095.

Robert Cohen, Interim Chief Executive Officer stated, “Given Zomedica’s current focus on diagnostic products, and specifically the commercialization of TRUFORMA™, we believe it to be appropriate at this time to simplify our corporate name. We continue to make good progress on our strategic initiatives and remain excited about our upcoming commercialization plans.”

About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include innovative diagnostics and therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to provide veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

• Email Alerts: http://investors.zomedica.com
• LinkedIn: https://www.linkedin.com/company/zomedica
• Facebook: https://www.facebook.com/zomedica/
• Twitter: https://twitter.com/zomedica

Investor Relations Contact:

PCG Advisory Group
Kirin Smith, COO
ksmith@pcgadvisory.com
+1 646.863.6519
www.pcgadvisory.com

FAQ

What is the significance of Zomedica changing its name to Zomedica Corp?

The name change reflects Zomedica's enhanced focus on point-of-care diagnostic products for companion animals.

When did Zomedica's name change become effective?

The name change became effective on October 5, 2020.

What will be the trading symbol for Zomedica after the name change?

Zomedica's trading symbol will remain ZOM on the NYSE American.

Was shareholder action needed for the name change of Zomedica?

No action was required by existing shareholders regarding the name change.

What were the results of the Zomedica shareholder meeting on September 25, 2020?

The shareholders approved the company's name change during the meeting on September 25, 2020.